Navigation Links
Impliant Restarts European Clinical Activities for Patented TOPS(TM) Spine System
Date:6/26/2008

PRINCETON, N.J., June 26 /PRNewswire/ -- Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that it has resumed European clinical activities on its TOPS(TM) System, a Total Posterior Arthroplasty device designed to treat spinal stenosis with or without facet arthrosis and spondylolisthesis. The procedure was performed by the Lead Clinician of the London Spine Clinic, Mr. John C. Sutcliffe, MB ChB, FRCS.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO )

Impliant had voluntarily suspended all clinical activities in September of last year following one device-related failure. After an extensive investigation conducted by a third-party expert in medical device retrievals and the Impliant Research and Development team, it was determined that device misalignment coupled with excessive shear loading caused the failure. As a result, Impliant has made a few minor design and manufacturing changes to the internal components of the TOPS(TM) device that allow it to better withstand high shear loads and misalignment while not affecting its range of motion.

"I am pleased with the changes Impliant has made to the TOPS(TM) System," said Mr. Sutcliffe. "I feel the device is now even better suited to stabilize the spinal segment after performing the wide decompression that my severely stenotic patients require. However, it should be noted that all of my patients with the original TOPS(TM) design continue to do extremely well, some of which have reached 12 months post-op."

Marcus Klarl, Vice President of European Clinical Affairs for Impliant, stated, "We are pleased to resume our TOPS(TM) clinical activities outside the United States and build upon the excellent outcomes generated to date by Mr. Sutcliffe and our other TOPS(TM) investigators."

The TOPS(TM) single and multi-level family of pro
'/>"/>

SOURCE Impliant, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. Launch of second European Cancer Research Funding survey
7. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
8. Pharsight to Host European Software Conference
9. OmniGuide Begins European Commercialization
10. Paving the way for future pan-European clinical trials
11. US, European cancer educators gather in Alabama for meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Scottsdale, AZ (PRWEB) , ... ... ... Services, Inc. (EMSI), a leading provider of medical information, risk management and ... the company’s evolution and direction toward focused, expert information solutions that improve ...
(Date:8/3/2015)... ... August 03, 2015 , ... Did you know that there ... looking for exceptional and affordable home care options which A-1 Home Care Agency specialize ... few of the credentials A-1 Home Care Agency is known for. ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, ... exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) conference being held in ... for the opportunity the AHDI conference provides us to interact with those in ...
(Date:8/2/2015)... ... August 03, 2015 , ... For many “would be” entrepreneurs, starting a new business ... “I can’t afford to start a business.” Neither needs be a major obstacle. , ... opportunity to start a business and be successful. The risks of starting a business can ...
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South ... for mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... South Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal ...
Breaking Medicine News(10 mins):Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2
... Sutter Spokesperson Admits Less Charity Care Required in Favored, Neighborhoods - New ... ... Luke,s, OAKLAND, Calif., Jan. 30 Sutter Health ... North of,Market CPMC campuses offer dramatically less charity care than St. Luke,s,Hospital, ...
... Inc. announced last week the acquisition of Mediplete, ... and southern California., (Logo: http://www.newscom.com/cgi-bin/prnh/20080130/AQW173 ), ... comes at the confluence of,two goals: for Mediplete, ... board for their clients in an IT-savvy environment, ...
... 30, 2008 In the years following the government ... reached almost epidemic levels. Were the federal guidelines a ... a well-meaning but unimportant factor" In a study published ... of Preventive Medicine, Paul R Marantz, MD, MPH, Elizabeth ...
... Authors of 1996 study that concluded differently took second ... (HealthDay News) -- A woman,s personality traits do not ... , In 1996, researchers at The Netherlands Cancer Institute ... and anti-emotionality, a lack of emotional behavior or trust ...
... 2008 Projected Financial Highlights and Potential Milestones include:, ... Marketing Authorization Application submission in Q1, - ... - Brostallicin phase II interim results ... MTAX: CTIC) announced today that with the return of ...
... 15,204 Square Foot Lease at Class-A Office Tower, ... one of the,largest development companies in the New ... relocate its U.S. headquarters,to Waterfront Corporate Center II, ... the Northeast. Octapharma, an independent, global plasma,fraction specialist, ...
Cached Medicine News:Health News:Government dietary guidelines, unintended consequences and public policy 2Health News:Government dietary guidelines, unintended consequences and public policy 3Health News:Personality Traits Don't Affect Breast Cancer Risk 2Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 2Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 3Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 4Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 5Health News:First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II 2Health News:First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II 3Health News:First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II 4
(Date:8/3/2015)... , August 3, 2015 ... FN Media Group LLC, PIV757417 The following release: ... Developing Orphan Drug Products & Treatments for Critical-Care ... HOLD. Distribution time: 3 Aug 2015 12:30 GMT ... biotech companies, military surgical research and top-tier universities ...
(Date:8/3/2015)... N.J. , Aug. 3, 2015  Celsion ... the Company will host a conference call to ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. EDT on Monday, August 10, 2015. To ...
(Date:8/3/2015)... , Aug. 3, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... to treat obesity, metabolic diseases and other gastrointestinal disorders, ... been appointed to the Board of Directors, effective July ... II Director until the 2018 annual meeting or until ... McDougal has served in an executive capacity in the ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: